Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
C&EN, November 12, 2018
Commitment to partnership and joint innovation for cell and gene therapies
C&EN, 26 September 2021
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025